A systematic review of dual targeting in HER2-positive breast cancerKÜMLER, Iben; TUXEN, Malgorzata K; NIELSEN, Dorte Lisbet et al.Cancer treatment reviews. 2014, Vol 40, Num 2, pp 259-270, issn 0305-7372, 12 p.Article

ALK inhibitors in the treatment of advanced NSCLCGRIDELLI, Cesare; PETERS, Solange; SGAMBATO, Assunta et al.Cancer treatment reviews. 2014, Vol 40, Num 2, pp 300-306, issn 0305-7372, 7 p.Article

Adherence enhancing interventions for oral anticancer agents: A systematic reviewMATHES, Tim; ANTOINE, Sunya-Lee; PIEPER, Dawid et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 102-108, issn 0305-7372, 7 p.Article

Adjuvant therapy for resectable pancreatic adenocarcinoma: Review of the current treatment approaches and future directionsANTONIOU, G; KOUNTOURAKIS, P; PAPADIMITRIOU, K et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 78-85, issn 0305-7372, 8 p.Article

Beyond EGFR TKI in EGFR-mutant Non-Small Cell Lung Cancer patients: Main challenges still to be overcomeREMON, J; MORAN, T; REGUART, N et al.Cancer treatment reviews. 2014, Vol 40, Num 6, pp 723-729, issn 0305-7372, 7 p.Article

Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologistsLANGE, Marie; RIGAL, Olivier; CLARISSE, Bénédicte et al.Cancer treatment reviews. 2014, Vol 40, Num 6, pp 810-817, issn 0305-7372, 8 p.Article

Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedinPOVEDA, Andrés; RAY-COQUARD, Isabelle; ROMERO, Ignacio et al.Cancer treatment reviews. 2014, Vol 40, Num 3, pp 366-375, issn 0305-7372, 10 p.Article

HER2 aberrations in cancer: Implications for therapyMIN YAN; PARKER, Barbara A; SCHWAB, Richard et al.Cancer treatment reviews. 2014, Vol 40, Num 6, pp 770-780, issn 0305-7372, 11 p.Article

HER2 testing: Current status and future directionsPEREZ, Edith A; CORTES, Javier; GONZALEZ-ANGULO, Ana Maria et al.Cancer treatment reviews. 2014, Vol 40, Num 2, pp 276-284, issn 0305-7372, 9 p.Article

Immunological challenges for peptide-based immunotherapy in glioblastomaMOHME, Malte; NEIDERT, Marian C; REGLI, Luca et al.Cancer treatment reviews. 2014, Vol 40, Num 2, pp 248-258, issn 0305-7372, 11 p.Article

Major molecular response during the first year of dasatinib, imatinib or nilotinib treatment for newly diagnosed chronic myeloid leukemia: A network meta-analysisSIGNOROVITCH, James; AYYAGARI, Rajeev; REICHMANN, William M et al.Cancer treatment reviews. 2014, Vol 40, Num 2, pp 285-292, issn 0305-7372, 8 p.Article

New drugs and targeted treatments in Hodgkin's lymphomaPROVENCIO, Mariano; SANCHEZ, Antonio; SANCHEZ-BEATO, Margarita et al.Cancer treatment reviews. 2014, Vol 40, Num 3, pp 457-464, issn 0305-7372, 8 p.Article

Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancerPEDDI, Parvin F; SHATSKY, Rebecca A; HURVITZ, Sara A et al.Cancer treatment reviews. 2014, Vol 40, Num 2, pp 320-326, issn 0305-7372, 7 p.Article

Osteosarcoma treatment ― Where do we stand? A state of the art reviewLUETKE, Anja; MEYERS, Paul A; LEWIS, Ian et al.Cancer treatment reviews. 2014, Vol 40, Num 4, pp 523-532, issn 0305-7372, 10 p.Article

Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapiesBECHET, Denise; MORDON, Serge R; GUILLEMIN, François et al.Cancer treatment reviews. 2014, Vol 40, Num 2, pp 229-241, issn 0305-7372, 13 p.Article

Predicting the risk of bone metastasis in prostate cancerBRIGANTI, Alberto; SUARDI, Nazareno; GALLINA, Andrea et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 3-11, issn 0305-7372, 9 p.Article

Retinoids and breast cancer: From basic studies to the clinic and back againGARATTINI, Enrico; BOLIS, Marco; ZAMBELLI, Alberto et al.Cancer treatment reviews. 2014, Vol 40, Num 6, pp 739-749, issn 0305-7372, 11 p.Article

Role of bisphosphonates in postmenopausal women with breast cancerGNANT, Michael.Cancer treatment reviews. 2014, Vol 40, Num 3, pp 476-484, issn 0305-7372, 9 p.Article

Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agentsBAHL, Amit; MASSON, Susan; BIRTLE, Alison et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 170-177, issn 0305-7372, 8 p.Article

Systematic review of combination therapies for mycosis fungoidesHUMME, Daniel; NAST, Alexander; ERDMANN, Ricardo et al.Cancer treatment reviews. 2014, Vol 40, Num 8, pp 927-933, issn 0305-7372, 7 p.Article

Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancerCIRUELOS GIL, Eva Maria.Cancer treatment reviews. 2014, Vol 40, Num 7, pp 862-871, issn 0305-7372, 10 p.Article

What to choose as radical local treatment for lung metastases from colo-rectal cancer: Surgery or radiofrequency ablation?SCHLIJPER, Roel C. J; GRUTTERS, Janneke P. C; DE RUYSSCHER, Dirk et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 60-67, issn 0305-7372, 8 p.Article

nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancerMEGERDICHIAN, Christine; OLIMPIADI, Yuliya; HURVITZ, Sara A et al.Cancer treatment reviews. 2014, Vol 40, Num 5, pp 614-625, issn 0305-7372, 12 p.Article

Infectious complications in cancer patients treated with anti-EGFR monoclonal antibodies cetuximab and panitumumab: A systematic review and meta-analysisFUNAKOSHI, Tomohiro; SUZUKI, Maya; TAMURA, Kazuo et al.Cancer treatment reviews. 2014, Vol 40, Num 10, pp 1221-1229, issn 0305-7372, 9 p.Article

Management of choroidal metastasesJARDEL, P; SAUERWEIN, W; HERAULT, J et al.Cancer treatment reviews. 2014, Vol 40, Num 10, pp 1119-1128, issn 0305-7372, 10 p.Article